Jefferies analyst Roger Song confirmed a Buy rating and a price target of $8.00 for IO Biotech (NASDAQ:IOBT) shares. The ...

Funds expected to be used to advance IO Biotech’s immune-modulating therapeutic cancer vaccines, including potential BLA submission for IO102-IO103 in 2025 Commitment is part of the European ...

Danish biotechnology company IO Biotech has finished enrolling subjects in a Phase II trial of its lead therapeutic cancer vaccine candidate, IO102-IO103, in conjunction with MSD's KEYTRUDA ...

IO Biotech (IOBT) entered into a loan facility of up to EUR 57.5M from the European Investment Bank. The debt facility includes three committed tranches totaling up to EUR 37.5M, which will become ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

IO Biotech, Inc., a pharmaceutical company with a market capitalization of $62 million, has been notified by The Nasdaq Stock Market LLC of non-compliance with its minimum bid price requirement.

IO Biotech, Inc., a pharmaceutical company with a market capitalization of $62 million, has been notified by The Nasdaq Stock Market LLC of non-compliance with its minimum bid price requirement. On ...

Diag-Nose.io launches Houston office to advance precise respiratory care using AI and proteomics after a successful $2M seed ...